Erica L. Jackson, Ph.D.
Dr. Jackson has been Scorpion Therapeutics’ Executive Vice President of Target Biology since October 2020. Prior to joining the company, Dr. Jackson was Senior Director of Tumor Dependencies and Oncology…
Dr. Jackson has been Scorpion Therapeutics’ Executive Vice President of Target Biology since October 2020. Prior to joining the company, Dr. Jackson was Senior Director of Tumor Dependencies and Oncology Discovery at AbbVie Inc. (“AbbVie”) between January 2020 and October 2020, following her tenure as Head of Biology at Pharmacyclics, an AbbVie company, that began in September 2018. Dr. Jackson also led the biology and in vivo pharmacology programs as Director of Biology at ORIC Pharmaceuticals, Inc. between 2016 and 2018.
Dr. Jackson holds a Bachelor’s Degree in Biology from Brandeis University and earned her Ph.D. in Biology from the Massachusetts Institute of Technology.